Global In-Vitro Diagnostics Market Industry Size, Trends, Growth, Share, Segments, Analysis, Overview and Forecast 2028

In-Vitro Diagnostics (IVD) Market: Industry Perspective

The report covers a forecast and an analysis of the in-vitro diagnostics (IVD) market on a global and regional level. The study provides historical data from 2015 to 2018 along with a forecast from 2019 to 2025 based on revenue (USD Million). The study includes drivers and restraints of the in-vitro diagnostics (IVD) market along with their impact on the demand over the forecast period. Additionally, the report includes the study of opportunities and threats to the in-vitro (IVD) market on a global level.

To understand the competitive landscape in the market, an analysis of Porter’s Five Forces Model for the in-vitro diagnostics (IVD) market has also been included. The study encompasses a market attractiveness analysis, wherein all the segments are benchmarked based on their market size, growth rate, and general attractiveness.

In-Vitro Diagnostics (IVD) Market by Product (Instruments, Reagents, and Services), by Technology (Immunology, Hematology, Clinical Chemistry, Molecular Diagnostics, Coagulation, Microbiology, and Others), by Application (Infectious Disease, Diabetes, Oncology, Cardiology, Nephrology, Autoimmune Diseases, Drug Testing, and Others), and by End-Use (Hospital, Laboratory, Home Care, and Others): Global Industry Perspective, Comprehensive Analysis, and Forecast, 2018–2025

The study provides a decisive view of the in-vitro diagnostics (IVD) market based on product, technology, application, end-use, and region. All the segments have been analyzed based on present and future trends and the market is estimated from 2019 to 2025. The regional segment includes the current and forecast demand for North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa with its further classification into major countries including the U.S., Germany, France, UK, China, Japan, India, and Brazil.

Read press release : https://www.zionmarketresearch.com/news/in-vitro-diagnostics-market

Antifog Additives Market Report Scope

REPORT ATTRIBUTES	DETAILS
Market Size in 2018 (USD)	USD 50,113 million in 2018
Revenue Forecast in 2025 (USD)	USD 70,730 million by 2025
Compound Annual Growth Rate (%)	CAGR of 5.01% from 2019 to 2025
Historic Data	2018 – 2020
Base Year	2021
Forecast Period	2022 – 2028
Segments Covered	Industry, Supply Chain, Service Type, Region
Leading Manufacturers Profiles	Alere, bioMerieux SA, Becton, Dickinson, and Company, F. Hoffmann-La Roche Ltd., Siemens Healthineers, Qiagen, Hologic, Inc. (Gen-Probe), Abbott, Danaher, Sysmex Corporation, and Cepheid
Geographical Reach	North America; Europe; Asia Pacific; Latin America; Middle East & Africa
Personalize/Buying Opportunities	Free Report Customization (equivalent up to 8 analyst’s working days) with purchase. Addition or alteration to country, regional & segment scope Avail customized purchase options to meet your exact research needs.

Some key players in the global in-vitro diagnostics (IVD) market are Alere, bioMerieux SA, Becton, Dickinson, and Company, F. Hoffmann-La Roche Ltd., Siemens Healthineers, Qiagen, Hologic, Inc. (Gen-Probe), Abbott, Danaher, Sysmex Corporation, and Cepheid.

Global in-vitro diagnostics (IVD) market expected to reach approximately USD 70,730 million by 2025, at a CAGR of around 5.01% between 2019 and 2025. In-vitro diagnostics (IVD) is used to identify various types of diseases and infections. In-vitro diagnostics products include reagents, instruments, etc. that are used for the infection analysis.